While Watrium refurbish its headquarters at Kanalen 5, Tjuvholmen in Oslo, Norway, the company will temporarily move to its Oslo Atrium office building at Dronning Eufemias gate 6A in Bjørvika in...
29th June 2020
2019 was an eventful year for Watrium, with several exciting new investments, overall strong development for the portfolio companies, attractive and well positioned real estate assets, and moving into 2020 from a position of strength with a robust balance sheet. The continued value creation from...
28th May 2020
Watrium continues its support of Oslo-listed Ultimovacs ASA through participation in a NOK 160 million private placement in the pharmaceutical company. Ultimovacs is developing novel immunotherapies against cancer. The net...
27th September 2019
CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius®, has raised £195 million ($240 million) to fully fund the global commercialisation of the business.
3rd June 2019
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen...
9th May 2019
Watrium supports the listing of DF Capital on AIM as cornerstone investor.
17th April 2019
Watrium partners with HitecVision by acquiring the interests of the Gjedebo family in HitecVision AS.
28th February 2019
Watrium’s portfolio company Flexiteek International, the global leader in synthetic teak decking and the 2G technology, has reached an agreement to acquire Wilks, manufacturer, and supplier of Dek-King synthetic teak...
17th October 2018
Watrium strengthens its investment team with two highly experienced investment professionals.
22nd June 2018
The combined entity of American Traffic Solutions, Highway Toll Administration and Watrium-owned Euro Parking Collection has rebranded to Verra Mobility and announced that the company will perform a reverse listing...
